Document is current
Any future updates will be listed below
-
Authors
Marcusohn, Erez
Manoragavan, Ragavie
Fremes, Stephen
Tarola, Christopher
Sathananthan, Janarthanan
Barabash, Israel M.
Orbach, Ady
Sachedina, Ayaaz K.
Radhakrishnan, Sam
Wijeysundera, Harindra C.
-
Funding
Funding for this research was provided by:
Edwards Lifesciences, Abbott Vascular, Medtronic, Boston Scientific, Anteris
Canada Research Chair in Structural Heart Policy and Outcomes
- License Information
-
More Information
Article History
Received: 14 April 2024
Accepted: 6 August 2024
First Online: 13 August 2024
Declarations
:
: The study was approved by the Sunnybrook institutional review board and patient consent was waived in light of the fact that CEP was indicated as per current clinical practice by the TAVI team.
: All authors have participated in the work and have reviewed and agree with the content of the article.
: Janarthanan Sathananthan: Consultant for Edwards Lifesciences, Abbott Vascular, Medtronic, Boston Scientific, Anteris. Research funding from Medtronic and Edwards Lifesciences.
